These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28692682)

  • 41. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute combined revascularization in acute ischemic stroke with intracranial arterial occlusion: self-expanding solitaire stent during intravenous thrombolysis.
    Šaňák D; Köcher M; Veverka T; Černá M; Král M; Buřval S; Školoudík D; Prášil V; Zapletalová J; Herzig R; Kaňovský P
    J Vasc Interv Radiol; 2013 Sep; 24(9):1273-9. PubMed ID: 23973019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.
    Rocco A; Sykora M; Ringleb P; Diedler J
    Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Internal cerebral vein asymmetry on follow-up brain computed tomography after intravenous thrombolysis in acute anterior circulation ischemic stroke is associated with poor outcome.
    Sharma VK; Yeo LL; Teoh HL; Shen L; Chan BP; Seet RC; Ahmad A; Chong VF; Paliwal PR
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e39-45. PubMed ID: 24119628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?
    Kass-Hout T; Kass-Hout O; Mokin M; Thesier DM; Yashar P; Orion D; Jahshan S; Hopkins LN; Siddiqui AH; Snyder KV; Levy EI
    World Neurosurg; 2014; 82(3-4):e453-8. PubMed ID: 23376392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.
    Jauss M; Schütz HJ; Tanislav C; Misselwitz B; Rosenow F
    Eur J Neurol; 2010 Apr; 17(4):555-61. PubMed ID: 20218973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leukoaraiosis and risk of intracranial hemorrhage and outcome after stroke thrombolysis.
    Yang CM; Hung CL; Su HC; Lin HJ; Chen CH; Lin CC; Hu HH; Lin SH; Sung PS
    PLoS One; 2018; 13(5):e0196505. PubMed ID: 29715283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Therapy in Acute Ischemic Stroke with Large Vessel Occlusion.
    Sugiura Y; Yamagami H; Sakai N; Yoshimura S;
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):766-771. PubMed ID: 27838178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
    Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
    Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke?
    Boehme AK; Kumar AD; Lyerly MJ; Gillette MA; Siegler JE; Albright KC; Beasley TM; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1939-43. PubMed ID: 24784010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analyses of the Turkish National Intravenous Thrombolysis Registry.
    Kutluk K; Kaya D; Afsar N; Arsava EM; Ozturk V; Uzuner N; Giray S; Topcuoglu MA; Gungor L; Sirin H; Yaka E; Ozdemir O; Dalkara T;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1041-1047. PubMed ID: 26853139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
    Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
    J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator.
    Huang YH; Zhuo ST; Chen YF; Li MM; Lin YY; Yang ML; Chen ZJ; Cai RW
    Chin Med J (Engl); 2013; 126(24):4685-90. PubMed ID: 24342312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.